RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @UMNconsortium: Very useful empirical research! Consortium Chair Susan M. Wolf is among the scholars who have advocated for the right no…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
Quite interesting. Convenience over privacy concerns on why people decline #genomics studies https://t.co/oWXfPBmOsa
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
Very useful empirical research! Consortium Chair Susan M. Wolf is among the scholars who have advocated for the right not to know; see https://t.co/9q8BUvFTCA. #ReturnofResults #ResearchEthics https://t.co/6Zjeb2lpeT
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
Not surprised the top reason was logistics, but privacy and discrimination concerns are still pretty substantial. #genomics https://t.co/XwVKaboqSz
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
Astonishing: only 13% of declining due to concerns about privacy and discrimination... https://t.co/bxU79qZkq3
RT @SCSanderson: Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & di…
Why do patients decline #genomics sequencing studies? Evidence from 1,088 US patients: study logistics (35%); privacy & discrimination concerns (13%); potential psychological burden of main findings (8%); not wanting secondary findings (2%) @hail_CSER
Out now! Provides motivation for rethinking how to center participant needs given broader life context when designing genomic studies https://t.co/geZCY8Cfw7
RT @CarrieBlout: Check out our new publication in the Journal of Genetic Counseling to learn "Why Patients Decline Genomic Sequencing Studi…
Check out our new publication in the Journal of Genetic Counseling to learn "Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium" @LauraAmendolaGC #GCchat https://t.co/7ntnW7Yv2k https://t.co/dTNoOe8Vcf
RT @Exome_seq: Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. https://t.co/qHGfS7Xjs5
RT @Exome_seq: Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. https://t.co/qHGfS7Xjs5
Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. https://t.co/qKatcaigDB